SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-038297
Filing Date
2023-10-25
Accepted
2023-10-25 17:25:21
Documents
26
Period of Report
2023-10-25
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42220
2 ex99-1.htm EX-99.1 138984
3 ex99-2.htm EX-99.2 264106
4 ex99-1_002.jpg GRAPHIC 2929555
5 ex99-1_003.jpg GRAPHIC 4684056
6 ex99-1_004.jpg GRAPHIC 2240644
7 ex99-2_001.jpg GRAPHIC 13962
8 ex99-2_002.jpg GRAPHIC 6030
9 ex99-2_003.jpg GRAPHIC 11782
10 ex99-2_004.jpg GRAPHIC 13607
11 ex99-2_005.jpg GRAPHIC 19524
12 ex99-2_006.jpg GRAPHIC 14647
13 ex99-2_007.jpg GRAPHIC 12348
14 ex99-2_008.jpg GRAPHIC 15368
  Complete submission text file 0001493152-23-038297.txt   14455317

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE bct-20231025.xsd EX-101.SCH 3744
16 XBRL DEFINITION FILE bct-20231025_def.xml EX-101.DEF 26582
17 XBRL LABEL FILE bct-20231025_lab.xml EX-101.LAB 36619
18 XBRL PRESENTATION FILE bct-20231025_pre.xml EX-101.PRE 25206
20 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5228
Mailing Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1
Business Address 3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR WEST VANCOUVER A1 V7T 2X1 (604) 921-1810
BriaCell Therapeutics Corp. (Filer) CIK: 0001610820 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-40101 | Film No.: 231346909
SIC: 2834 Pharmaceutical Preparations